Prescription medicine
Thiamine
Thiamine is a prescription medicine. FDA's NDC Directory lists it from 18 generic labelers, and pharmacies paid $2.25 per mL (Thiamine 200 mg/2 mL vial) in the October 7, 2026 NADAC survey.
- Generic listed
Check it at the source: the thiamine FDA label on DailyMed (effective July 22, 2026, Sagent Pharmaceuticals); every thiamine label on DailyMed.
Highlights of the record
FDA label of July 22, 2026; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026; NADAC October 7, 2026
Used for
From the label: indications and usageThiamine Hydrochloride Injection is effective for the treatment of thiamine deficiency or beriberi whether of the dry (major symptoms related to the nervous system) or wet (major symptoms related to the cardiovascular system) variety.
Forms and strengths
- 100 mg/ml
- 200 mg/2ml
Injection (solution).
On the market
- Generic approvals
- 18 first June 20, 1972; 12 with a marketed status in Drugs@FDA
- Labelers listed (NDC)
- 18 of which 18 under generic applications, 0 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- $2.25 per mL Thiamine 200 mg/2 mL vial
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- 2 since 2012 0 Class I among all firms' recalls; latest February 5, 2026; 11 more by firms not listed as its makers
- FAERS reports
- 12,374 through July 30, 2026
What is thiamine used for?
From the label: indications and usageThiamine Hydrochloride Injection is effective for the treatment of thiamine deficiency or beriberi whether of the dry (major symptoms related to the nervous system) or wet (major symptoms related to the cardiovascular system) variety. Thiamine Hydrochloride Injection should be used where rapid restoration of thiamine is necessary, as in Wernicke's encephalopathy, infantile beriberi with acute collapse, cardiovascular disease due to thiamine deficiency, or neuritis of pregnancy if vomiting is severe. It is also indicated when giving IV dextrose to individuals with marginal thiamine status to avoid precipitation of heart failure. […]
Source: FDA drug label (thiamine hydrochloride), Sagent Pharmaceuticals, effective July 22, 2026 (SPL set 5982cf83-01d6-4acb-8373-339079b8a76e), via openFDA; the full label on DailyMed
Is there a generic for thiamine?
The FDA approved the first generic thiamine on June 20, 1972. 18 generic applications are approved; 12 of them carry a current (not discontinued) marketing status in Drugs@FDA; that status is not evidence that the generic is on sale.
FDA's NDC Directory lists thiamine from 18 labelers under a generic (ANDA) application. A listing means the company has registered the product for sale; it does not show that every pharmacy stocks it.
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
What do pharmacies pay for thiamine?
In CMS's NADAC survey of October 7, 2026, pharmacies paid $2.25 per mL (Thiamine 200 mg/2 mL vial), down 18% from $2.73 on October 8, 2025. The chart's scale runs from the lowest to the highest price shown, not from zero. NADAC is what retail pharmacies paid their wholesalers, per unit, in CMS's monthly survey; what a patient pays depends on insurance and the pharmacy.
- Thiamine 200 mg/2 mL vial (generic)
| Strength and form | Brand or generic | Pharmacy cost | 30 tablets, or one pen or vial | 12-month change |
|---|---|---|---|---|
| Thiamine 200 mg/2 mL vial | Generic | $2.25 per mL | $4.49 per vial | -18% |
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
Has thiamine been recalled?
The FDA's Enforcement Report lists 13 recalls naming thiamine since 2012: 0 Class I (the most serious), 12 Class II, 1 Class III; 1 still ongoing. 11 of them are by firms that FDA's NDC Directory does not list as a maker of thiamine and that hold no application for it in Drugs@FDA, such as compounding pharmacies or bulk-ingredient suppliers; the recall notice names the product recalled. A recall names products and lots, not every product of the medicine.
| Started | Class | Company | Reason |
|---|---|---|---|
| February 5, 2026 | Class II | Fresenius Kabi Compounding, LLC | Lack of Assurance of Sterility |
| December 8, 2022 | Class II | McGuff Compounding Pharmacy Services, Inc. not a listed maker | Presence of Particulate Matter: Presence of foreign substances were reported in vials at the pharmacy. |
| May 3, 2021 | Class III | Mylan Institutional LLC | Labeling: Incorrect or Missing Lot and/or Exp Date: Cartons with the correct lot number 200906 contain vials labeled with the incorrect lot number 200901. |
| June 19, 2019 | Class II | RXQ Compounding LLC not a listed maker | Lack of Assurance of Sterility |
| May 13, 2016 | Class II | Medaus, Inc. not a listed maker | Lack of Assurance of Sterility |
| November 10, 2015 | Class II | Walgreens Infusion Services not a listed maker | Lack of Assurance of Sterility |
| October 16, 2015 | Class II | Downing Labs, LLC not a listed maker | Lack of Assurance of Sterility |
| December 26, 2014 | Class II | Walgreens Infusion Services not a listed maker | Lack of sterility assurance. |
Source: FDA Enforcement Report (drug recalls) via openFDA, through October 8, 2026
What does the thiamine label say about other medicines?
The thiamine label names 1 other medicine in its interaction, contraindication or warning sections. The labels of 17 other medicines name thiamine. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.
| Medicine named | Section | What the label says |
|---|---|---|
| Epinephrine | warnings | Treatment of anaphylactic reactions includes maintaining a patent airway and the use of epinephrine, oxygen, vasopressors, steroids and antihistamines. |
Other labels that name thiamine
Source: FDA drug label (thiamine hydrochloride), Sagent Pharmaceuticals, effective July 22, 2026 (SPL set 5982cf83-01d6-4acb-8373-339079b8a76e), via openFDA; the full label on DailyMed
What do FAERS reports show for thiamine?
The FDA Adverse Event Reporting System holds 12,374 reports that list thiamine among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 1,943 are coded as a death and 6,753 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
Reports received each year
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What next?
- Thiamine side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other